Results for tag: "Hepatic Impairment Drugs"

The Hepatic Impairment Drugs market is a subset of the Liver and Kidney Disorders Drugs market. It focuses on drugs used to treat diseases and conditions that affect the liver, such as hepatitis, cirrhosis, and fatty liver disease. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Commonly prescribed drugs include antivirals, immunosuppressants, and antifibrotics. The Hepatic Impairment Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Bristol-Myers Squibb. Other companies include Novartis, AstraZeneca, and Roche. Show Less Read more